Magazine Article | January 1, 2017

Beyond Oncology — Precision Medicine For Autoimmune Diseases

By Dr. Georg Lautscham, chief business officer (CBO), and Dr. Stefan Müllner, CEO and cofounder, Protagen

Precision medicine (also known as personalized medicine) offers a more efficient mode of drug development for the pharmaceutical industry, as well as promising more-effective therapeutic tools for physicians and better outcomes for patients.

While it has been reasonably well-applied in the field of oncology, the ongoing development of novel technologies and changes in the regulatory landscape are essential if the approach is to be effectively applied to other important therapeutic areas.

THIS CONTENT IS EXCLUSIVELY FOR LIFE SCIENCE LEADER PAID SUBSCRIBERS.
To continue reading this story and receive uninterrupted access to LSL Online and its monthly magazine subscribe to Life Science Leader today!
Already a subscriber? Log in now.